In the Supplementary Information of this Article, on pages 3, 8 and 11, we refer to “UK Patent Application No. 1522431.4”, which pertains to the discovery of the truncated peptide analogues we used1, and specifically to the use of the modified N terminus or ‘Cap’. This patent application mentions another patent, which we cite here2. The original Article has not been corrected.
References
Andrews, A., Congreve, M., Bortolato, A. & Mason, J. Novel GLP-1 receptor agonist peptides. UK patent application GB1522431.4 (2017)
Kodra, J. T. & Madsen, J. GLP-1 receptor agonist compounds with a modified N-terminus. Worldwide patent WO2011073328 (2011)
Additional information
The online version of the original article can be found at 10.1038/nature22800
Rights and permissions
About this article
Cite this article
Jazayeri, A., Rappas, M., Brown, A. et al. Correction: Corrigendum: Crystal structure of the GLP-1 receptor bound to a peptide agonist. Nature 548, 122 (2017). https://doi.org/10.1038/nature23311
Published:
Issue Date:
DOI: https://doi.org/10.1038/nature23311
This article is cited by
-
Full-length human GLP-1 receptor structure without orthosteric ligands
Nature Communications (2020)
Comments
By submitting a comment you agree to abide by our Terms and Community Guidelines. If you find something abusive or that does not comply with our terms or guidelines please flag it as inappropriate.
